Life Sciences IT Global Market Opportunities And Strategies To 2035

Life Sciences IT Market Definition

Life Sciences information technology (IT) refers to the application of information technology systems, software, and digital infrastructure to support operations in the pharmaceutical, biotechnology, medical device, and healthcare sectors. The primary purpose of Life Sciences IT is to enable efficient data management, regulatory compliance, and digital transformation across research, development, manufacturing, and commercialization processes. The life sciences IT market consists of sales by entities (organizations, sole traders and partnerships) of life sciences IT primarily used by pharmaceutical companies, biotechnology firms, contract research organizations, research laboratories, healthcare institutions and regulatory bodies to manage scientific data, streamline research workflows, improve collaboration and ensure compliance with regulatory standards. These solutions are used throughout the lifecycle of life sciences activities, from early-stage drug discovery and preclinical research to clinical trials, regulatory submissions, manufacturing and post-market surveillance. It includes solutions such as laboratory information management systems (LIMS), clinical trial management systems (CTMS), electronic lab notebooks (ELN), bioinformatics platforms, data analytics tools, cloud computing, and cybersecurity systems tailored to regulated environments.

Life Sciences IT Market Segmentation The life sciences IT market is segmented by type, by solution, by end user.

By Type –
The life sciences IT market is segmented by type into:

• a) Software
• b) Service

The service market was the largest segment of the life sciences IT market segmented by type, accounting for 60.9% or $17,741.3 million of the total in 2025. Going forward, the software segment is expected to be the fastest-growing segment in the life sciences IT market segmented by type, at a CAGR of 12.7% during 2025-2030.

By Solution –
The life sciences IT market is segmented by solution into:

• a) Drug Discovery Informatics
• b) Clinical Trial Management
• c) Bioinformatics
• d) Laboratory Information Management
• e) Other Solutions

The drug discovery informatics was the largest segment of the life sciences IT market segmented by solution, accounting for 29.8% or $8,678.7 million of the total in 2025. Going forward, the bioinformatics segment is expected to be the fastest-growing segment in the life sciences IT market segmented by solution, at a CAGR of 12.7% during 2025-2030.

By End User –
The life sciences IT market is segmented by end user into:

1. a) Pharmaceutical And Biotechnology Companies
2. b) Contract Research And Development Organizations
3. g) Other End Users

The pharmaceutical and biotechnology companies market was the largest segment of the life sciences IT market segmented by end user, accounting for 63.1% or $18,396.8 million of the total in 2025. Going forward, the contract research and development organizations segment is expected to be the fastest-growing segment in the life sciences IT market segmented by end user, at a CAGR of 13.0% during 2025-2030.

By Geography - The life sciences IT market is segmented by geography into:

o Asia Pacific
• China
• India
• Japan
• Australia
• Indonesia
• South Korea
o North America
• USA
• Canada
o South America
• Brazil
o Western Europe
• France
• Germany
• UK
• Italy
• Spain
o Eastern Europe
• Russia
o Middle East
o Africa

North America was the largest region in the life sciences IT market, accounting for 36.4% or $10,617.1 million of the total in 2025. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the life sciences IT market will be Asia Pacific and Eastern Europe where growth will be at CAGRs of 13.2% and 11.4% respectively. These will be followed by Western Europe and North America where the markets are expected to grow at CAGRs of 11.2% and 10.3% respectively.

Life Sciences IT Market Drivers

The key drivers of the life sciences IT market include: Rising Healthcare Spending During the forecast period, rising healthcare spending is expected to be a key driver the growth in the life sciences IT market. As governments and healthcare systems continue to increase investments in healthcare infrastructure, medical research and digital health capabilities, the demand for advanced information technology solutions in life sciences is expected to expand significantly. Higher healthcare expenditures support the adoption of data management platforms, digital research tools and advanced analytics systems that help organizations improve operational efficiency, enhance clinical research capabilities and accelerate drug development processes. The growing financial commitment toward healthcare systems and biomedical innovation is expected to encourage pharmaceutical companies, research institutions and healthcare providers to adopt advanced life sciences IT solutions, supporting continued growth in the life sciences IT market. The growth in rising healthcare spending growth contribution during the forecast period in 2025 is 2.0%.

Life Sciences IT Market Restraints

The key restraints on the life sciences IT market include: Integration Challenges With Legacy IT Infrastructure During the forecast period, integration challenges with legacy IT infrastructure are restricting the growth of the life sciences IT market. Increasing reliance on advanced digital platforms such as electronic health records, clinical data management systems and cloud-based research environments is creating operational difficulties for organizations that still depend on older health information technology systems. From a functional and infrastructure perspective, many healthcare organizations operate with outdated software architectures and fragmented data environments that lack interoperability with newer technologies, making it difficult to achieve seamless data exchange and system coordination. These technological limitations, combined with the technical complexity of upgrading legacy systems, are increasing hesitation among healthcare providers and research organizations regarding the large-scale deployment of life sciences IT solutions that require fully integrated digital infrastructure. Growth affected by integration challenges with legacy IT infrastructure during the forecast period in 2025 is -2.0%.

Life Sciences IT Market Competitive Landscape

Major Competitors are:

IQVIA Holdings Inc.

Oracle Corp.

Accenture plc

Veeva Systems

SAP SE

Other Competitors Include:

Great Robotics Corporation

Intuitive Surgical, Inc.

Stryker Corporation

Johnson & Johnson

CMR Surgical Ltd.

Zimmer Biomet Holdings, Inc.

Beijing Tuodao Medical Technology Co., Ltd.

THINK Surgical, Inc.

Moon Surgical SAS

Activ Surgical, Inc.

Curexo, Inc.

Stereotaxis, Inc.

Koh Young Technology Inc.

Quantum Surgical SAS

Smith & Nephew plc

Globus Medical, Inc.

Siemens Healthineers AG

Life Sciences IT Market Trends

Major trends shaping the life sciences IT market include: Integration Of Quantum Computing And Advanced Computational Platforms In Life Sciences Companies operating in the life sciences IT market are increasingly focusing on the development of quantum computing, enabled research platforms, advanced computational chemistry tools and integrated digital discovery environments. These innovations combine high-performance computing, quantum simulation technologies and advanced modeling tools to enable more accurate analysis of complex chemical reactions, support faster molecular design and reduce the time required for pharmaceutical and materials development. For instance, in August 2025, Mitsui & Co., Ltd., a Japan-based diversified trading and investment company involved in advanced technology and innovation initiatives, partnered with QSimulate, a US-based computational chemistry software company and Quantinuum, a US-based quantum computing technology company, to launch QIDO (Quantum-Integrated Discovery Orchestrator), a quantum-integrated chemistry platform designed to accelerate research and development in drug and materials discovery. The platform combines advanced classical computing with quantum computing capabilities to enable high-precision chemical reaction modeling, streamline hybrid quantum-classical workflows and help organizations reduce the time and cost associated with developing new drugs and advanced materials. Adoption Of AI-Driven Commercialization And Marketing Automation Platforms Key players operating in the life sciences IT market are focusing on the development of artificial intelligence-driven commercialization platforms, cloud-based marketing ecosystems and advanced data analytics tools. These innovations combine generative AI, cloud computing infrastructure and large-scale life sciences datasets to automate marketing workflows, enhance omnichannel communication and enable faster development of compliant promotional and educational content. For instance, in August 2025, EVERSANA, a US-based provider specializing in commercialization services and technology solutions for the life sciences industry, announced the development of an end-to-end AI-powered life sciences marketing agency built on Google Cloud technology. The platform leverages Google Cloud’s AI capabilities, including Gemini models operating on the Vertex AI platform, to automate a wide range of agency operations such as strategy development, omnichannel campaign planning and content creation, enabling pharmaceutical companies to accelerate marketing operations while integrating AI-driven insights across commercialization workflows.

Opportunities And Recommendations In The Life Sciences IT Market

Opportunities – The top opportunities in the life sciences IT market segmented by type will arise in the service segment, which will gain $11,319.3 million of global annual sales by 2030. The top opportunities in the life sciences IT market segmented by solution will arise in the drug discovery informatics segment, which will gain $6,058.0 million of global annual sales by 2030. The top opportunities in the life sciences IT market segmented by end user will arise in the pharmaceutical and biotechnology companies segment, which will gain $12,520.1 million of global annual sales by 2030. The life sciences IT market size will gain the most in the USA at $6,106.3 million. Recommendations- To take advantage of the opportunities, The Business Research Company recommends the life sciences IT companies to focus on quantum-enabled integrated discovery ecosystems, focus on AI driven commercialization platforms in life sciences IT, focus on integrated ai driven cloud inspection platforms for manufacturing visibility, focus on integrated cloud ecosystems and data-driven collaboration in life sciences IT, focus on expanding software driven life sciences IT solutions for high growth analytics and saas adoption, focus on strengthening geographic and digital distribution channels for life sciences IT expansion, focus on value linked pricing and contract structuring in life sciences IT, focus on digital-first targeted promotion for life sciences IT buyers, focus on multi-channel scientific credibility promotion, focus on domain skilled talent and user enablement across life sciences IT adoption.